JB Chemicals & Pharmaceuticals Q1 Results
- BSE: 506943
- NSE: JBCHEPHARM
- ISIN: INE572A01036
- Sector: Biotechnology & Drugs
BSE
1,793.95
-5.05 (-0.28%)
-5.05 (-0.28%)Volume3.18 K
Updated: Tue 21 Jan, 2025 | 15:29:00
NSE
1,791.55-10.90 (-0.60%)
-10.90 (-0.60%)Volume1.14 L
Updated: Tue 21 Jan, 2025 | 15:30:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - JB Chemicals & Pharmaceuticals Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 24 | Mar 24 | QoQ Comp | Jun 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1,004.40 | 861.73 | 16.56% | 896.20 | 12.07% |
| Selling/ General/ Admin Expenses Total | 166.91 | 152.70 | 9.31% | 148.75 | 12.21% |
| Depreciation/ Amortization | 40.78 | 40.74 | 0.10% | 31.38 | 29.96% |
| Other Operating Expenses Total | 217.37 | 210.63 | 3.20% | 205.37 | 5.84% |
| Total Operating Expense | 764.81 | 704.35 | 8.58% | 695.47 | 9.97% |
| Operating Income | 239.59 | 157.38 | 52.24% | 200.73 | 19.36% |
| Net Income Before Taxes | 239.84 | 164.60 | 45.71% | 194.30 | 23.44% |
| Net Income | 176.83 | 126.16 | 40.17% | 142.32 | 24.25% |
| Diluted Normalized EPS | 11.16 | 7.83 | 42.59% | 9.07 | 23.04% |